Adebrelimab and Chidamide for Pancreatic Cancer
NCT06584227
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer, Adult
Interventions
DRUG:
Adebrelimab and Chidamide Combined with Gemcitabine and S1
Sponsor
Liu Xiufeng